FDAnews Device Daily Bulletin

GUIDANT ANNOUNCES ENROLLMENT OF FIRST PATIENT IN LANDMARK CAROTID ARTERY STENTING STUDY

March 21, 2006
A A

Guidant Corporation today announced that the first patient has been enrolled in a new post-approval study of carotid artery stenting in high surgical risk patients, called CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events). WebWire (http://webwire.com/ViewPressRel.asp?SESSIONID=&aId=11244)